Dr Reddy's launches autoinjector system in US

Pharma major Dr Reddy's Laboratories (DRL) today said it has launched Sumatriptan Injection USP in the US.

The injection is an autoinjector system for subcutaneous use. It is a therapeutic equivalent generic version of Imitrex Statdose Pen (sumatriptan succinate) and was launched in the US market today following approval by the United States Food & Drug Administration (USFDA), a company statement said here.